$AGIO Recent News S&P 500 returns to scene of
Post# of 145263
Posted On: 10/04/2014 11:11:26 AM
$AGIO Recent News
S&P 500 returns to scene of the breakdown 10:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 11:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 7:28 a.m. April 7, 2014 - Sara Sjolin
Agios to Present Data on AG-120 in November, Shares Rises - Analyst Blog 5:30 p.m. Sept. 29, 2014 - Zacks.com
Cramer's Mad Money - 7 Things To Watch In The Week Ahead (9/26/14) 6:08 a.m. Sept. 28, 2014 - Seeking Alpha
'Fast Money' Recap: Why Volatility Might Be a Good Thing 5:00 a.m. Sept. 27, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:14 p.m. Sept. 26, 2014 - TheStreet.com
Agios hits new high 1:12 p.m. Sept. 26, 2014 - Seeking Alpha
Agios' Early Drug-Trial Report Cheers Wall Street 12:21 p.m. Sept. 26, 2014 - Investors Business Daily
Jim Cramer's Stop Trading: Does Agios Pharmaceuticals Have a Monumental Cancer Treatment? 11:58 a.m. Sept. 26, 2014 - TheStreet.com
Agios (AGIO) is in Overbought Territory: What's Next? - Tale of the Tape 10:12 a.m. Sept. 26, 2014 - Zacks.com
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's New Lifetime High Stock 9:46 a.m. Sept. 26, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO) Gains: Stock Up 6.4% - Tale of the Tape 8:44 a.m. Sept. 26, 2014 - Zacks.com
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios 7:00 a.m. Sept. 26, 2014 - TheStreet.com
Agios Pharmaceuticals To Present Clinical Data From AG-120 Ongoing Phase 1 Study In Hematologic Malignancies At EORTC-NCI-AACR 2014 6:32 a.m. Sept. 26, 2014 - benzinga.com
Strong On High Relative Volume: Agios Pharmaceuticals (AGIO) 10:04 a.m. Sept. 19, 2014 - TheStreet.com
Jim Cramer's Top Stock Picks: AGIO AAPL LUV 6:00 a.m. Sept. 17, 2014 - TheStreet.com
Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14) 5:29 a.m. Sept. 17, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Let's Hear It for the Bull 8:20 p.m. Sept. 16, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO): Today's Weak On High Volume Stock 10:08 a.m. Sept. 12, 2014 - TheStreet.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Aug. 27, 2014 - InvestorPlace.com
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q2 2014 Results - Earnings Call Transcript 4:10 p.m. Aug. 9, 2014 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 5:17 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver 9:31 a.m. Sept. 29, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014 7:30 a.m. Sept. 26, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable 4:06 p.m. Sept. 23, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation 8:30 a.m. Aug. 13, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 1:38 p.m. Aug. 12, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results 7:31 a.m. Aug. 7, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 11:14 a.m. July 31, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014 9:01 a.m. July 28, 2014 - GlobeNewswire
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 1:30 p.m. July 15, 2014 - PR Newswire - PRF
Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner 9:00 a.m. July 14, 2014 - PR Newswire - PRF
Orphan Drug Designations, Financial Results, Board Elections, and Raised Financial Guidance - Analyst Notes on Agios, Alder, Healthways, NeoGenomics and Sequenom 6:10 a.m. July 2, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Orphan Drug Designation of AG-221 for Treatment of Acute Myelogenous Leukemia 8:02 a.m. June 16, 2014 - BusinessWire - BZX
New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies 7:31 a.m. June 14, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration 8:03 a.m. June 13, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for the Potential Treatment of PK Deficiency, a Rare, Hemolytic Anemia 8:02 a.m. June 9, 2014 - BusinessWire - BZX
Strategic Acquisitions, Clinical Data Presentations, Research Grants, and Technical Updates - Analyst Notes on Acadia, Opko Health, Arrowhead Research, Agios Pharmaceuticals and Sangamo Biosciences 5:10 a.m. June 6, 2014 - PR Newswire - PRF
Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation 9:00 a.m. June 5, 2014 - PR Newswire - PRF
S&P 500 returns to scene of the breakdown 10:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 11:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 7:28 a.m. April 7, 2014 - Sara Sjolin
Agios to Present Data on AG-120 in November, Shares Rises - Analyst Blog 5:30 p.m. Sept. 29, 2014 - Zacks.com
Cramer's Mad Money - 7 Things To Watch In The Week Ahead (9/26/14) 6:08 a.m. Sept. 28, 2014 - Seeking Alpha
'Fast Money' Recap: Why Volatility Might Be a Good Thing 5:00 a.m. Sept. 27, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:14 p.m. Sept. 26, 2014 - TheStreet.com
Agios hits new high 1:12 p.m. Sept. 26, 2014 - Seeking Alpha
Agios' Early Drug-Trial Report Cheers Wall Street 12:21 p.m. Sept. 26, 2014 - Investors Business Daily
Jim Cramer's Stop Trading: Does Agios Pharmaceuticals Have a Monumental Cancer Treatment? 11:58 a.m. Sept. 26, 2014 - TheStreet.com
Agios (AGIO) is in Overbought Territory: What's Next? - Tale of the Tape 10:12 a.m. Sept. 26, 2014 - Zacks.com
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's New Lifetime High Stock 9:46 a.m. Sept. 26, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO) Gains: Stock Up 6.4% - Tale of the Tape 8:44 a.m. Sept. 26, 2014 - Zacks.com
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios 7:00 a.m. Sept. 26, 2014 - TheStreet.com
Agios Pharmaceuticals To Present Clinical Data From AG-120 Ongoing Phase 1 Study In Hematologic Malignancies At EORTC-NCI-AACR 2014 6:32 a.m. Sept. 26, 2014 - benzinga.com
Strong On High Relative Volume: Agios Pharmaceuticals (AGIO) 10:04 a.m. Sept. 19, 2014 - TheStreet.com
Jim Cramer's Top Stock Picks: AGIO AAPL LUV 6:00 a.m. Sept. 17, 2014 - TheStreet.com
Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14) 5:29 a.m. Sept. 17, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Let's Hear It for the Bull 8:20 p.m. Sept. 16, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO): Today's Weak On High Volume Stock 10:08 a.m. Sept. 12, 2014 - TheStreet.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Aug. 27, 2014 - InvestorPlace.com
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q2 2014 Results - Earnings Call Transcript 4:10 p.m. Aug. 9, 2014 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 5:17 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver 9:31 a.m. Sept. 29, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014 7:30 a.m. Sept. 26, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable 4:06 p.m. Sept. 23, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation 8:30 a.m. Aug. 13, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 1:38 p.m. Aug. 12, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results 7:31 a.m. Aug. 7, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 11:14 a.m. July 31, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014 9:01 a.m. July 28, 2014 - GlobeNewswire
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 1:30 p.m. July 15, 2014 - PR Newswire - PRF
Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner 9:00 a.m. July 14, 2014 - PR Newswire - PRF
Orphan Drug Designations, Financial Results, Board Elections, and Raised Financial Guidance - Analyst Notes on Agios, Alder, Healthways, NeoGenomics and Sequenom 6:10 a.m. July 2, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Orphan Drug Designation of AG-221 for Treatment of Acute Myelogenous Leukemia 8:02 a.m. June 16, 2014 - BusinessWire - BZX
New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies 7:31 a.m. June 14, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration 8:03 a.m. June 13, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for the Potential Treatment of PK Deficiency, a Rare, Hemolytic Anemia 8:02 a.m. June 9, 2014 - BusinessWire - BZX
Strategic Acquisitions, Clinical Data Presentations, Research Grants, and Technical Updates - Analyst Notes on Acadia, Opko Health, Arrowhead Research, Agios Pharmaceuticals and Sangamo Biosciences 5:10 a.m. June 6, 2014 - PR Newswire - PRF
Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation 9:00 a.m. June 5, 2014 - PR Newswire - PRF
(0)
(0)